These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 22332769)
61. Response to sorafenib after sunitinib-induced acute heart failure in a patient with metastatic renal cell carcinoma: case report and review of the literature. Wong MK; Jarkowski A Pharmacotherapy; 2009 Apr; 29(4):473-8. PubMed ID: 19323623 [TBL] [Abstract][Full Text] [Related]
62. [Impact of immunotherapy in metastatic kidney cancer in Germany after introduction of new target therapy--results of a telephone survey of the German Society of Immuno- and Targeted Therapy (DGFIT)]. Siebels M; Staehler M; Hegele A; Varga Z; Oberneder R; Doehn C; Heinzer H; Aktuelle Urol; 2010 Mar; 41(2):122-30. PubMed ID: 19937556 [TBL] [Abstract][Full Text] [Related]
63. Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma. Hahn OM; Yang C; Medved M; Karczmar G; Kistner E; Karrison T; Manchen E; Mitchell M; Ratain MJ; Stadler WM J Clin Oncol; 2008 Oct; 26(28):4572-8. PubMed ID: 18824708 [TBL] [Abstract][Full Text] [Related]
65. Use of sorafenib in two metastatic renal cell cancer patients with end-stage renal impairment undergoing replacement hemodialysis. Ferraris E; Di Cesare P; Lasagna A; Paglino C; Imarisio I; Porta C Tumori; 2009; 95(4):542-4. PubMed ID: 19856673 [TBL] [Abstract][Full Text] [Related]
66. [Molecular targeted therapy for renal cell carcinoma and other urological cancers]. Miyake H; Fujisawa M Nihon Rinsho; 2010 Oct; 68(10):1871-5. PubMed ID: 20954332 [TBL] [Abstract][Full Text] [Related]
69. Experience with sorafenib and the elderly patient. Dutcher JP; Tannir N; Bellmunt J; Escudier B Med Oncol; 2010 Dec; 27(4):1359-70. PubMed ID: 20043216 [TBL] [Abstract][Full Text] [Related]
70. Management of sorafenib, sunitinib, and temsirolimus toxicity in metastatic renal cell carcinoma. Guevremont C; Alasker A; Karakiewicz PI Curr Opin Support Palliat Care; 2009 Sep; 3(3):170-9. PubMed ID: 19528803 [TBL] [Abstract][Full Text] [Related]
71. Re: Sequential sorafenib and sunitinib for renal cell carcinoma M. P. Sablin, S. Negrier, A. Ravaud, S. Oudard, C. Balleyguier, J. Gautier, C. Celier, J. Medioni and B. Escudier J Urol 2009; 182: 29-34. Di Lorenzo G; Autorino R J Urol; 2010 Feb; 183(2):824-5; author reply 825. PubMed ID: 20022057 [No Abstract] [Full Text] [Related]
72. Efficacy of sunitinib and sorafenib in non-clear cell renal cell carcinoma: results from expanded access studies. Strumberg D J Clin Oncol; 2008 Jul; 26(20):3469-71; author reply 2471. PubMed ID: 18612169 [No Abstract] [Full Text] [Related]